Unknown

Dataset Information

0

Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis.


ABSTRACT: We recently developed a partial peptide of receptor activator of nuclear factor-кB ligand (RANKL) known as microglial healing peptide 1 (MHP1-AcN), that inhibits Toll-like receptor (TLR)-related inflammation through RANKL/RANK signaling in microglia and macrophages without promoting osteoclast activation. The abnormal activation of TLRs contributes to the initiation and maintenance of psoriasis, which is a chronic inflammatory skin disease that involves the aberrant expression of proinflammatory cytokines and the subsequent dermal γδ T cell and T helper 17 (Th17) cell responses. The inhibition of TLR-mediated inflammation provides an important strategy to treat psoriasis. Here, we examined the preventative effects of MHP1-AcN in a mouse model of imiquimod (a TLR 7/8 agonist)-induced psoriasis. Topical imiquimod application induced psoriasis-like skin lesions on the ear and dorsal skin. Systemic administration of MHP1-AcN by daily subcutaneous injection significantly prevented the development of skin lesions, including erythema, scaling and thickening. Mice treated with MHP1-AcN showed reduced levels of skin Il6 mRNA at 32 h and reduced levels of Il23 and Il17a mRNA at d9. Serum levels of IL-6 and IL-23 were reduced at 32 h, and IL-17A was reduced at d9. These results indicated that MHP1-AcN could decrease imiquimod-induced IL-6, IL-23 and IL-17A production. MHP1-AcN is potentially an alternative treatment for psoriasis.

SUBMITTER: Ju N 

PROVIDER: S-EPMC6817907 | biostudies-other | 2019 Oct

REPOSITORIES: biostudies-other

altmetric image

Publications

Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis.

Ju Nan N   Shimamura Munehisa M   Hayashi Hiroki H   Ikeda Yuka Y   Yoshida Shota S   Nakamura Ayumi A   Morishita Ryuichi R   Rakugi Hiromi H   Nakagami Hironori H  

Scientific reports 20191028 1


We recently developed a partial peptide of receptor activator of nuclear factor-кB ligand (RANKL) known as microglial healing peptide 1 (MHP1-AcN), that inhibits Toll-like receptor (TLR)-related inflammation through RANKL/RANK signaling in microglia and macrophages without promoting osteoclast activation. The abnormal activation of TLRs contributes to the initiation and maintenance of psoriasis, which is a chronic inflammatory skin disease that involves the aberrant expression of proinflammatory  ...[more]

Similar Datasets

| S-EPMC7558091 | biostudies-literature
2017-10-06 | GSE104603 | GEO
| PRJNA413303 | ENA
2023-06-15 | GSE152637 | GEO
| S-EPMC6608051 | biostudies-literature
| S-EPMC7844923 | biostudies-literature
| S-EPMC8512696 | biostudies-literature
| S-EPMC8114823 | biostudies-literature
| S-EPMC5345243 | biostudies-literature
| S-EPMC7751755 | biostudies-literature